Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia by Yong, Hua-Hie et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1111/add.14182
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Yong, H-H., Borland, R., Cummings, K. M., & Partos, T. (2018). Do predictors of smoking relapse change as a
function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia.
Addiction, 113(7), 1295-1304. https://doi.org/10.1111/add.14182
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 29. Apr. 2020
  1 of 15 
Do predictors of smoking relapse change as a function of duration of abstinence? Findings 
from the United States, Canada, United Kingdom and Australia  
 
Hua-Hie Yong PhD1, Ron Borland PhD1, K. Michael Cummings PhD2, Timea Partos PhD3  
 
1 Nigel Gray Fellowship Group, Cancer Council Victoria, Melbourne, Australia  
2 Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, 
Charleston, USA 
3 Department of Addictions, Institute of Psychiatry, Psychology, and Neuroscience, King’s College 
London, UK  
 
Word count: 4340  
 
Running head: Time-varying effects of smoking relapse predictors  
 
Declaration of interests  
Dr. Cummings has received grant funding from Pfizer, Inc. to study the impact of a hospital based 
tobacco cessation intervention and also has served as an expert witness in litigation filed against the 
tobacco industry. None of the other authors has any conflict of interest to declare.  
 
Corresponding author: Hua Yong, PhD 
615 St Kilda Rd,  
Melbourne VIC 3004, Australia  
Tel: 61-3-9514-6283  
Fax: 61-3-9514-6800  
E-mail: hua.yong@cancervic.org.au  
 
 
ABSTRACT 
 
Aims To estimate predictors of time to smoking relapse and test if prediction varied by quit 
duration. 
Design Longitudinal cohort data from the International Tobacco Control Four-Country survey with 
annual follow up collected between 2002 and 2015. Setting Canada, US, UK and Australia. 
Participants A total of 9,171 eligible adult smokers who made at least one quit attempt over the 
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study period. Measurements Time to relapse was the main outcome. Predictor variables included 
pre-quit baseline measures of nicotine dependence, smoking and quitting related motivations, 
quitting capacity, and social influence, and also two post-quit measures, use of stop-smoking 
medications and quit duration (1-7 days, 8-14 days, 15-31 days, 1-3 months, 3-6 months, 6-12 
months, 1-2 years and 2+ years), along with socio- demographics. Findings All factors were 
predictive of relapse within the first six months of quitting but only wanting to quit, quit intentions 
and number of friends who smoke were still predictive of relapse in the 6-12 months period of 
quitting (hazard ratios [HR]=1.20, p=.018; 1.13, p=.040; and 1.21, p<.001, respectively). Number 
of friends smoking was the only remaining predictor of relapse in the 1-2 years quit period 
(HR=1.19, p=.001) with none predictive beyond the 2 years quit period. Use of stop-smoking 
medications during quit attempts was negatively related to relapse in the first two weeks of quitting 
(HR=.71-.84) but positively related to relapse in the 1-6 months quit period (HR=1.29-1.54). 
Predictive effects of all factors showed significant interaction with quit duration except for 
perceiving smoking as an important part of life, prematurely stubbing out a cigarette and wanting to 
quit. Conclusions Among adult smokers in the US, Canada, UK and Australia, factors associated 
with smoking relapse differ between the early and later stages of a quit attempt suggesting the 
determinants of relapse change as a function of abstinence duration. 
Keywords: smoking relapse, time-varying effects, survival analysis, duration of abstinence  
 
  
INTRODUCTION  
 
Tobacco control efforts have been remarkably successful at getting smokers to try to quit (1), but 
have been far less successful in helping them to maintain abstinence. The most recent Cochrane 
review concluded again that there is nothing much that prevents longer term relapse from attempts 
to quit smoking although some behavioural interventions and long term use of a nicotine 
replacement show promise (2). Most past research has focused on encouraging smokers to make 
quit attempts. Based on the now well-established understanding that factors associated with making 
quit attempts are not necessarily the same as those associated with quit maintenance (1, 3), recent 
efforts have shifted towards understanding what might prevent smoking relapse among those who 
try. Identified predictors of relapse include nicotine dependence (4), smoking and quitting related 
motivations (1, 5), low self-efficacy (6), social influences (7) and not using smoking cessation aids 
(4). It is estimated that even with help around 85% who quit successfully will relapse back to 
smoking within a year (8) and even after prolonged periods of abstinence, relapse is still possible, 
underscoring the need to understand not just short and medium term relapse risk but also long-term 
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risk (9).  
 The few attempts to theorise the determinants of maintenance have focused on the time it 
takes to extinguish the habit (overcoming dependence), and on the limits of self-control (e.g., 
Piasecki et al. (10); Borland (11)). These theories suggest different determinants of relapse as a 
function of these two factors which relate approximately to the amount of time quit. In our work, 
we have identified three possible phases of quitting: (1) an initial implementation period which may 
last several days; (2) then a period of consolidation where there is a restored need for active self-
regulation; and (3) finally, a synthesis period where staying quit stops being a primary focal 
activity, although occasional vigilance is still required as long- term habits develop and old ones 
extinguish. These distinctions, based on the Context, Executive and Operational Systems (CEOS) 
theory (11), have been operationalised in the QuitCoach, an automated personalised cessation 
program (12), which has shown evidence of preventing relapse (13). The use of medication to 
reduce cravings is theorised to provide a period for new habits to develop but if the medication use 
is stopped before the new habit is stabilized, then the consolidation period may be prolonged 
resulting in cessation fatigue when self-control resources are depleted (10) and this may increase 
relapse rates during the synthesis phase.  
 Research to date has mostly focused on studying predictors of short, medium and long term 
relapses separately with no attempt to understand how relapse predictors might vary over the course 
of qutting (e.g., Caraballo et al (14); Gokbayrak et al (15); Kerr et al (9); Swan et al (16)). 
Consequently, relatively little attention has been paid to tailoring stop-smoking interventions to the 
length of time that an individual has been abstinent from smoking. Consistent with the 
aforementioned theories, there is emerging evidence that the determinants of relapse in the long 
term are different to those in the short term (17, 18). For example, the Heaviness of Smoking Index 
(HSI), a well-established behavioural measure of nicotine dependence, has been shown to be 
predictive of relapse only in the first few weeks of quitting (18) and not beyond. Other predictors of 
smoking relapse had not been studied before but would be expected to vary by quit duration as well. 
The CEOS theory would predict that highly dependent smokers who report making a quit attempt 
with the help of stop-smoking medications (SSM) would have lower odds of relapse in the initial 
weeks of quitting but once they are off SSM, they may be more vulnerable to relapse. Reported 
number of friends smoking may not be predictive of relapse in the early days of quitting when 
smokers concentrate on staying quit but become strongly predictive of relapse once quitting is no 
longer the focus. A better understanding of how the predictive effects of known predictors of 
relapse might change over time quit would help inform how best to tailor interventions that are time 
sensitive.  
 The present study extends the analysis reported by Yong et al (18) with the aim of 
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investigating, among adult smokers in the US, Canada, UK and Australia, whether and how the 
strength of association with time to relapse of known predictors of smoking relapse varied as a 
function of duration of abstinence. Specifically, the study aimed to (1) estimate the strength of 
association between the set of factors known to predict relapse and time to relapse; and (2) test 
whether strength of association with time to relapse for this set of factors, all measured before the 
target quit attempt except for use of stop-smoking medication which was asked retrospectively in 
relation to the target quit attempt, varied by duration of abstinence. Differential predictors were 
examined in periods ranging from the first week to over 2 years post quit. It is hoped that the 
findings might help identify factors to assist ex- smokers with remaining abstinent for the long 
term. Apart from expecting HSI to lose its strength of association after around 1 month quit (18), 
we had no strong predictions, but an expectation that valuing smoking and having smoking 
embedded in their lifestyle (e.g., having lots of smoking friends) might be more likely to be 
predictive over longer periods.  
 
 
METHODS  
 
Design  
Longitudinal cohort survey with approximately annual follow up conducted between 2002 and 
2015.  
 
Data source and sample  
Data come from Waves 1 to 9 of the International Tobacco Control Four Country (ITC-4) survey, a 
cohort study of broadly representative samples of around 2000 adult smokers per country per wave 
followed up approximately annually in Australia, Canada, the UK and the US. To maintain the 
sample size at each subsequent wave, those lost to attrition were replenished using the same 
sampling procedures as in Wave 1. The broad aim of the ITC-4 was to evaluate the psychosocial 
and behavioural impact of tobacco control policies on smokers. Full details of the ITC conceptual 
model and methodology have been published elsewhere (19, 20). Briefly, respondents were 
recruited into the study as smokers who met the following criteria: aged 18+ years, had smoked at 
least 100 cigarettes in their lifetime, and smoked at least once in the past 30 days. Participants who 
subsequently quit smoking were retained in the study. To be eligible for the study, respondents had 
to be a smoker at the baseline wave (Wave T), to have provided valid data for the selected predictor 
variables at this wave, and to have made a quit attempt lasting at least 1 day by the next survey 
wave (Wave T+1), and to have provided outcome data on that attempt either at that wave, or for 
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those still quit at subsequent waves after the target attempt. The study sample (see Table 1 for 
sample characteristics) consisted of 9,171 participants who met our inclusion criteria.  
 
Measures  
Predictor variables: This set of pre-quit variables was assessed at the most proximal wave prior to 
quitting and were selected based on their known relationship with relapse (17). They included 
several measures of nicotine-dependence [Heaviness of Smoking index modified version derived 
based on square-root transformed cigarettes per day, CPD and natural log transformed time to first 
cigarette of the day, TTFC (21), perceived difficulty of quitting, and past year failed quit attempts], 
two measures of smoking functional value (enjoyment and important part of life), measures of 
quitting-related motivation and capacity (wanting to quit, quit intentions, and quitting self-efficacy), 
micro-behavioural indicator of health concern about smoking (premature stubbing out) and social 
influence (number of friends smoking). The question wording along with response option and mean 
levels (SD) are presented in Table 2.  
 
Outcome variable: Time to relapse was the main outcome. At each follow-up, respondents were 
asked their smoking status. If quit, they were coded as having made a quit attempt since the last 
survey and were asked how long ago they quit. If smoking, they were asked whether they had tried 
to quit since the previous wave, and if so, the duration of the quit attempt. For those who made 
multiple attempts since the previous wave, they were asked the duration of their most recent 
attempt. For those who were quit at two or more successive waves, their quit duration was 
computed by adding on the exact inter-wave interval, plus any reported durations within inter-wave 
intervals. The quit length information was then used to derive time to relapse in days for each 
individual. Relapse was defined as any quit attempt that ended in failure (i.e., resumed smoking at 
least monthly) identified at a given follow-up assessment. Because of coding complexity, only one 
quit attempt (typically the first one) was coded for analysis for participants who made multiple quit 
attempts over the study period.  
 
Control variables: These included age, sex, annual household income, highest level of education, 
country of residence, and cohort (i.e., year recruited into the study).  
 
Statistical analysis  
All analyses were conducted in Stata 14.1. The association between the set of predictor variables 
and time to relapse was modelled using survival analysis. Our modelling strategy used a fully 
parametric approach, parameterised as a proportional hazard model. We modelled the underlying 
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distribution of time using the Weibull distribution. Given that preliminary analyses indicated that 
the predictor variables were low to moderately correlated with each other (r=.01-.58), we first fitted 
separate partially adjusted models (model A) for each of the predictors and then, we fitted a fully 
adjusted model (model B) whereby the full set of predictor variables was entered simultaneously 
into the model to determine their independent effect on relapse. To test our hypothesis that the 
effect of some predictors was not constant over time (time-varying coefficient), we fitted 
interactions between time quit and the set of predictors. To this end, we expanded our dataset into 8 
unequal time-intervals (1-7 days, 8-14 days, 15-31 days, 1-3 months, 3-6 months, 6-12 months, 1-2 
years and 2+ years) using the stsplit command for survival data. The intervals were chosen to reflect 
the differential changes over time in theorized predictors of relapse, following either a logarithmic 
or square-root function (22), and also to maximise the number in each time interval, shorter interval 
at the beginning to reflect the more rapid rate of relapse and progressively longer to correspond to 
the slower rate as quit attempt progresses over time. Participants were classified into each time 
interval as follows: all participants were included in the first time interval (i.e., 1-7 days, this 
cutpoint was chosen because of the long follow- up period of the survey making finer distinctions 
difficult) and those who survived (i.e., still quit) were included in the next time interval (i.e., 8-14 
days) but those who had relapsed were excluded. This was repeated for each subsequent interval for 
those still quit until they had relapsed or were lost to attrition or were censored at the end of study 
period. All models controlled for potential confounders such as age, sex, income, education, and 
country, and also adjusted for any within-cohort clustering using clustered sandwich estimators. We 
reported hazard ratios (HR) as an index of the strength of the association between predictor 
variables and time to relapse over the eight intervals of interest. They are interpreted as the effect of 
a 1 unit change in the predictor variable over the interval of interest on the risk of relapse.  
 
 
RESULTS  
 
Over the study period, 9,171 adult smokers who met the study criteria were included in the survival 
analysis where 31,522 data points were analyzed across the 8 time quit intervals, of which 25,004 
were censored (1,966 due to drop-outs) and 6,518 were failures (see Table 1 for details by time quit 
interval). The overall survival curve is presented in supplementary Figure S1.  
Table 3 presents the results from the partially and fully adjusted models showing the association 
between the set of predictors and relapse at each time quit interval. Measures of nicotine 
dependence such as HSI and its components (CPD and TTFC) were all significantly associated with 
relapse in the first 6 months in the partially adjusted model and first 3 months in the fully adjusted 
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model but not beyond. Their strength of association also diminished over time quit intervals 
(significant interaction with time quit). Interestingly, while the predictive effect of CPD and TTFC 
was similar in the partially adjusted model, it differed in the fully adjusted model whereby TTFC 
was only predictive of relapse in the first week of quitting whereas CPD was predictive up to 3 
months. Hard to quit, another measure of dependence, was predictive of relapse in the first 3 
months of quitting in the partially adjusted model but in the fully adjusted model, was predictive 
only in the first week of quitting, and unexpectedly, became protective at the 1-2 year period of 
quitting.  
 Enjoyment and important part of life measures showed different patterns of prediction. 
Partially adjusted model revealed that enjoyment was not predictive of relapse at any of the time 
quit intervals whereas important part of life was predictive in the first month of quitting. However, 
the fully adjusted model indicated that enjoyment was a significant predictor within the first 6 
months of quitting with evidence of a significant interaction with time quit interval whereas the 
effect for important part of life measure had now reversed showing, being protective, but only for 
relapse occurring within 1-2 weeks and 1-3 month period.  
 Premature stubbing out, a behavioural measure of health concern, was predictive of relapse 
between 8 days and 3 months of quitting in the partially adjusted model but only within the first 
month in the fully adjusted model with no significant interaction with time quit interval for either 
model.  
 The three measures of quit related motivation (ie., past year failed quit attempts, wanting to 
quit and quit intentions) all showed quite different patterns of prediction. Partially adjusted model 
revealed that past year failed quit attempts were predictive of relapse in the first 6 months of 
quitting with the predictive effect increasing over time (significant by time quit interval interaction). 
In the fully adjusted model, this measure remained predictive in the first 6 months of quitting except 
for the second week but the predictive effect no longer differed over the different time periods (by-
time quit interval interaction was not significant). Wanting to quit, on the other hand, was predictive 
of relapse between 8 days and 1 year in the partially adjusted model except for the 3-6 month period 
but in the fully adjusted model it was only predictive between 8 and 14 days. Plans to quit was 
predictive of relapse beyond one month and up to 1 year of quitting in the partially adjusted model 
with that effect increasing over time quit intervals but was no longer predictive in the fully adjusted 
model once other predictors were controlled for.  
 Number of friends smoking, a measure of social influence, predicted relapse that occurred 
beyond 2 weeks up to 6 months and again in the 1-2 year period but was predictive throughout the 
first two years in the fully adjusted model with the effect appearing to peak at the 3-6 month time 
interval (significant by-time quit interval interaction).  
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Unlike the aforementioned measures, self-efficacy was protective against relapse in the first 3 
months of quitting with the effect diminishing in the partially adjusted model but remained constant 
in the fully adjusted model.  
 Reported use of any stop-smoking medication for the attempt was protective against relapse 
in the first 2 weeks of quitting, and then it became predictive of relapse from 1-6 months with 
similar pattern for both partially and fully adjusted models (interaction with time quit, both 
significant).  
As a sensitivity analysis, we repeated the fully adjusted analysis without the wanting to quit variable 
(asked from Wave 3 onwards) in the model. The only noticeable difference in results (see Table S1) 
was that the significant effects of the two measures of smoking functional value were no longer 
evident indicating some complex interactive effects with the wanting to quit measure. Further 
analyses revealed that the effects of enjoyment and important part of life measures on relapse and 
how they varied over time quit were moderated by wanting to quit, dichotomized into “a lot” versus 
“other” (enjoyment x time quit x want to quit interaction significant at p=.054 and important x time 
quit x want to quit interaction significant at p=.038). As shown in Table S2, the predictive effect of 
enjoyment belief, both its strength and trend over time, was attenuated when wanting to quit was 
strong. Important part of life belief was predictive of relapse in the 1 to 2 years quit period but only 
for the group who expressed a strong wanting to quit. However, this belief was protective against 
relapse that occurred beyond 2 years but only for the group without a strong wanting to quit.  
In addition, we also explored the sociodemographic effects and found older age was protective 
against relapse starting around 1 month while higher income and education were protective in the 
early weeks and months of quitting with gender having no effect at all (see Table S3).  
 
 
DISCUSSION  
 
This study shows that a wide variety of theorized determinants of smoking relapse have time- 
varying relationships with relapse, suggesting that their roles in maintaining smoking abstinence 
change over time. It confirms the findings of Yong et al (18) and shows that measures of nicotine 
dependence such as HSI and its two component measures (CPD and TTFC) lost their potency as 
determinants of relapse after around 1-3 months. The present study found HSI to be predictive of 
relapse up to 3 months, rather than the one month of abstinence in Yong et al (18). Cigarettes per 
day showed similar pattern of prediction, being predictive up to 3 months but time to first cigarette 
was less predictive than before, becoming non-predictive after 1 week post quitting. The slight 
disparity in findings may have been due to a combination of the larger sample size, controlling for a 
  9 of 15 
range of other predictors and the use of alternate version of the HSI in the present study. The minor 
differences notwithstanding, it is clear that these measures only capture aspects of dependence 
relating to habit strength and not those related to the chronic relapsing nature of smoking, unlike 
reported strong urges to smoke post quit which have been shown to be predictive of long-term 
relapse (17). This brings into question the use of the HSI as a general measure of dependence.  
 As expected and consistent with past research (18), use of stop-smoking medications during 
quit attempts was protective in the early weeks of quitting but once people stop using them, some of 
the risk returns. In other words, when medications are in use, they mask the effects of some risk 
factors for relapse (e.g., factors that generate cravings) but because these underlying factors remain, 
people are more vulnerable to relapse when they stop the medications. Given that the increased 
relapse is far smaller than the early protective effect, it suggests that only some of the benefit has 
been lost. It may be that longer use of medications would allow for further reduction in the 
underlying determinants. If so, some smokers may benefit from using stop-smoking medications 
longer term (23). The protective effect of higher socioeconomic status in the first weeks of quitting 
may reflect greater resources and support available to those from advantaged background during 
this period (24) but whatever it is, it does not persist. There was no effect for age in the early period, 
but beyond 1-month post quit, older quitters were less likely to relapse, perhaps a function of extra 
motivation due to experiences of the negative health impact of smoking (25) or of perceived 
improvements in short-term functioning, thus, increasing their motivation to quit for good (26).  
 Interestingly, motivational factors, both smoking (i.e., enjoyment and important part of life) 
and quitting related ones (i.e., premature butting out of cigarettes, past failed quit attempts, wanting 
to quit and plans to quit) were all positively related to relapse with little evidence of interactions 
with time quit, particularly when the effects of other predictor variables were taken into 
consideration. The finding that the measures of motivation to quit predict relapse is consistent with 
other findings (1, 3), and has been interpreted to be because those highly motivated who were still 
smoking may be people with greater than normal difficulty in maintaining abstinence. That these 
effects largely persisted in the face of other measures of dependence suggests they are picking up 
something that these other measures are not able to. Of interest is the complex interactive effect 
found between the two measures of smoking functional value and desire to quit whereby the 
positive predictive effect of enjoyment belief and the unexpected protective effect of perceiving 
smoking as an important part of life became weakened in the context of a strong desire to quit. 
These findings suggest that once people have resolved to quit, they can counteract any positive 
value they hold about smoking and even to the extent of it having a protective effect on relapse.  
 Consistent with past research (6), quitting self-efficacy, a measure of capacity/task 
difficulty, showed a protective effect on relapse but was only predictive up to 6-month post quit 
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with similar strength of association suggesting that pre-quit measure of self-efficacy is only useful 
for predicting relapse in the first six month of quitting. This is not surprising given that past 
research suggests that both the stable and dynamic components of quitting self-efficacy are 
important determinants of relapse (6, 17, 27), the latter being a function of the experiences of the 
task difficulty post quit.  
 Evidence of number of friends who smoke being predictive of relapse up to 2 years of 
abstinence suggests that social influence may have a more enduring effect on relapse than other 
determinants of relapse, which is consistent with the idea that a stable non-smoking lifestyle takes 
time, especially when others in their social circle are still smoking. Consistent with past research (7, 
17), number of friends who smoke have less of an influence on relapse in the early weeks of 
quitting when people are focusing on quitting and may make extra efforts to avoid smoking friends 
but over time as priority shifts, people may not be able to keep this up making them more 
vulnerable to relapse.  
 The findings of this study are consistent with models that suggest a shift in the determinants 
of relapse within months of quitting. More research is needed to see if markers of any abrupt 
transitions can be found or whether this is a more gradual transformation. The time-sensitive nature 
of the effects found may help explain why current efforts to prevent long-term relapse have not 
been very successful, as they may have been targeting potential influences at the wrong times, or at 
least not warning quitters of how the risks may change. In the early periods of quitting, highly 
dependent smokers and those who hold strong functional beliefs about smoking are at greater risk 
of relapse and may benefit from intervention that boosts their self-confidence in quitting. They 
might also be encouraged to use stop-smoking medications to help them cope better with 
withdrawal symptoms. Those who have managed to survive a month, especially those with a history 
of past failures, may need help to transition from a period when quitting is a focal activity, to one 
where vigilance and the ability to reengage when needed may be more important. Finally, for those 
with lots of smoking friends, they need to be aware of the persisting risk, and unless they are 
prepared to shift friendship group towards non-smokers, they will need ongoing strategies to resist 
the inevitable temptations others smoking brings.  
 
Strengths and limitations  
The study strengths include prospective cohort design, large sample size, data from multiple 
countries and a comprehensive set of key known predictors of relapse. However, several study 
limitations warrant discussion. First, our findings were based on self-report data which may be 
affected by recall and social desirability biases. This is most likely a problem for short quit attempts 
given our rather long interwave intervals, so more caution should be exercised in interpreting the 
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findings of relapse within the first week (28). Second, only pre- quit predictor variables were 
analyzed and as some of them are known to change over time quit (22), the effects of those factors 
are likely to be underestimated, particularly for longer term outcomes. Self-efficacy is the most 
notable case here. Future research should endeavor to measure them (where possible) over the 
course of the attempt to assess the dynamic elements of the predictors. Third, risk estimates for 
longer term relapse are less reliable as they are based on smaller samples. Fourth, given drop-out 
rate was higher in the later time quit intervals, risk could be underestimated if those having relapsed 
were more likely to drop out. Fifth, social influence dimension is not well captured as the number of 
friends smoking variable may be confounded with general social support. Lastly, only one quit 
attempt per individual over the study period was coded for analyses. However, the findings are 
likely to be robust to effects of past quitting given our fully adjusted results were based on models 
which controlled for reported past year failed quit attempts. Beyond this, failed attempts are poorly 
reported (28).  
 
Conclusions  
This study provides evidence to support the notion that some determinants of relapse vary over the 
duration of abstinence suggesting that their relative importance in influencing relapse changes 
across the different stages of quitting and underscore the need for some level of a time-based 
approach to relapse prevention. In particular, the findings that measures of dependence used here 
typically only predicted in the early months mean these measures would seem insensitive to the 
chronic relapsing aspect of dependence. These measures may be better thought of as measures of 
habit strength, rather than as comprehensive measures of dependence. The implications of these 
findings for relapse prevention will only become clear once research identifies which of these 
factors play likely causal roles in increasing relapse susceptibility.  
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